PL370536A1 - Kompozycje do leczenia przeziębienia - Google Patents
Kompozycje do leczenia przeziębieniaInfo
- Publication number
- PL370536A1 PL370536A1 PL02370536A PL37053602A PL370536A1 PL 370536 A1 PL370536 A1 PL 370536A1 PL 02370536 A PL02370536 A PL 02370536A PL 37053602 A PL37053602 A PL 37053602A PL 370536 A1 PL370536 A1 PL 370536A1
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- common cold
- treatment
- salt
- combination
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 201000009240 nasopharyngitis Diseases 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- YGWFCQYETHJKNX-UHFFFAOYSA-N 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1h-imidazol-3-ium;chloride Chemical compound [Cl-].CC1=CC(C(C)(C)C)=CC(C)=C1CC1=NCC[NH2+]1 YGWFCQYETHJKNX-UHFFFAOYSA-N 0.000 abstract 1
- 208000036071 Rhinorrhea Diseases 0.000 abstract 1
- 206010039101 Rhinorrhoea Diseases 0.000 abstract 1
- 239000000812 cholinergic antagonist Substances 0.000 abstract 1
- OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 abstract 1
- 229960001888 ipratropium Drugs 0.000 abstract 1
- 210000002850 nasal mucosa Anatomy 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 239000005526 vasoconstrictor agent Substances 0.000 abstract 1
- 229960001095 xylometazoline hydrochloride Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Polyurethanes Or Polyureas (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101356 | 2001-09-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL370536A1 true PL370536A1 (pl) | 2005-05-30 |
| PL208686B1 PL208686B1 (pl) | 2011-05-31 |
Family
ID=8160714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL370536A PL208686B1 (pl) | 2001-09-18 | 2002-09-18 | Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US7652030B2 (pl) |
| EP (2) | EP1446119B1 (pl) |
| JP (1) | JP4500045B2 (pl) |
| KR (1) | KR100810872B1 (pl) |
| CN (1) | CN1290502C (pl) |
| AT (1) | ATE318601T1 (pl) |
| BR (1) | BRPI0212586B8 (pl) |
| CA (1) | CA2460140C (pl) |
| DE (1) | DE60209511T2 (pl) |
| DK (1) | DK1446119T3 (pl) |
| EA (1) | EA008165B1 (pl) |
| ES (1) | ES2259098T3 (pl) |
| HU (1) | HU226527B1 (pl) |
| MX (1) | MXPA04002500A (pl) |
| NO (1) | NO334441B1 (pl) |
| NZ (1) | NZ531792A (pl) |
| PL (1) | PL208686B1 (pl) |
| PT (1) | PT1446119E (pl) |
| SI (1) | SI1446119T1 (pl) |
| WO (1) | WO2003024433A2 (pl) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| EP1446119B1 (en) * | 2001-09-18 | 2006-03-01 | Nycomed Danmark ApS | Compositions comprising ipatropium and xylometazoline for treatment of the common cold |
| TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
| JP2007520509A (ja) * | 2004-02-06 | 2007-07-26 | メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト | 抗コリン薬による、又は抗ヒスタミン薬、ホスホジエステラーゼ４、又はコルチコステロイドとの組み合わせによる鼻炎治療薬 |
| WO2005084330A2 (en) * | 2004-03-02 | 2005-09-15 | Synergia Pharma, Inc. | Compositions and methods for treating nasal congestion |
| DE102004049008A1 (de) * | 2004-10-05 | 2006-04-06 | Merck Patent Gmbh | Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur |
| EP1830886B1 (en) * | 2004-12-27 | 2016-04-13 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
| DE102006023770A1 (de) * | 2006-05-20 | 2007-11-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Treibgasfreie Aerosolformulierung für die Inhalation |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| US20090270472A1 (en) * | 2008-04-25 | 2009-10-29 | Kenneth Gould | Method to use oxymetazoline to interrupt the development of the common cold syndrome |
| US10011906B2 (en) | 2009-03-31 | 2018-07-03 | Beohringer Ingelheim International Gmbh | Method for coating a surface of a component |
| JP5763053B2 (ja) | 2009-05-18 | 2015-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アダプタ、吸入器具及びアトマイザ |
| EP2504051B1 (en) | 2009-11-25 | 2019-09-04 | Boehringer Ingelheim International GmbH | Nebulizer |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| AP3141A (en) | 2009-11-25 | 2015-02-28 | Boehringer Ingelheim Int | Nebulizer |
| JP5874724B2 (ja) | 2010-06-24 | 2016-03-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| WO2014158118A1 (en) * | 2013-03-29 | 2014-10-02 | Santa Farma İlaç Sanayi̇ A.Ş. | Suspension composition containing ipratropium and oxymetazoline |
| EP2978407B1 (en) * | 2013-03-29 | 2020-05-06 | Santa Farma Ilaç Sanayi A.S. | Aqueous solution composition containing ipratropium and oxymetazoline |
| ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
| US9744313B2 (en) | 2013-08-09 | 2017-08-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2015054359A1 (en) * | 2013-10-08 | 2015-04-16 | Ebadi Mark A | Methods and compositions for symptomatic reflief of the common cold |
| CN106255554B (zh) | 2014-05-07 | 2021-05-04 | 勃林格殷格翰国际有限公司 | 容器、喷雾器及用途 |
| ES2874029T3 (es) | 2014-05-07 | 2021-11-04 | Boehringer Ingelheim Int | Nebulizador |
| PE20210959A1 (es) | 2014-05-07 | 2021-05-25 | Boehringer Ingelheim Int | Nebulizador, dispositivo indicador y recipiente |
| UA117544C2 (uk) * | 2014-12-24 | 2018-08-10 | Ядран - Галенскі Лабораторій Д.Д. | Назальна композиція із вмістом морської води як ексципієнтом, що покращує стабільність |
| MX383771B (es) | 2015-12-02 | 2025-03-14 | Pablo Cortes Borrego | Combinación de oximetazolina e ipratropio en aplicación tópica nasal para el tratamiento de la tos. |
| US20220031739A1 (en) * | 2020-07-31 | 2022-02-03 | Eye Therapies Llc | Anti-viral compositions and methods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08508007A (ja) * | 1991-11-19 | 1996-08-27 | センター フォー イノベイティブ テクノロジー | ウィルス抑止性抗両受体によるかぜの複合治療法 |
| IL101056A (en) | 1992-02-24 | 1997-03-18 | Res & Dev Co Ltd | Composition for nasal treatment |
| GB9218834D0 (en) | 1992-09-05 | 1992-10-21 | Procter & Gamble | Nasal spray products |
| ES2129117T3 (es) * | 1992-12-09 | 1999-06-01 | Boehringer Ingelheim Pharma | Formulaciones en disolucion en forma de aerosol medicinales estabilizadas. |
| EP0780127A1 (en) | 1995-12-19 | 1997-06-25 | The Procter & Gamble Company | A nasal spray containing a steroid and a antihistamine |
| DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
| IL131492A0 (en) | 1997-04-30 | 2001-01-28 | Warner Lambert Co | Topical nasal antiinflammatory compositions |
| IL136591A (en) * | 1998-01-30 | 2005-08-31 | Novartis Consumer Health Sa | Nasal pharmaceutical solutions |
| ATE253896T1 (de) | 1998-06-18 | 2003-11-15 | Boehringer Ingelheim Pharma | Zwei oder mehrere wirkstoffe enthaltende pharmazeutische aerosolformulierungen |
| AU765736B2 (en) * | 1999-06-22 | 2003-09-25 | Boehringer Ingelheim International Gmbh | Stable xylometazoline and oxymetazoline solution |
| EP1446119B1 (en) * | 2001-09-18 | 2006-03-01 | Nycomed Danmark ApS | Compositions comprising ipatropium and xylometazoline for treatment of the common cold |
-
2002
- 2002-09-18 EP EP02765268A patent/EP1446119B1/en not_active Expired - Lifetime
- 2002-09-18 CA CA002460140A patent/CA2460140C/en not_active Expired - Lifetime
- 2002-09-18 BR BRPI0212586A patent/BRPI0212586B8/pt not_active IP Right Cessation
- 2002-09-18 DE DE60209511T patent/DE60209511T2/de not_active Expired - Lifetime
- 2002-09-18 JP JP2003528530A patent/JP4500045B2/ja not_active Expired - Lifetime
- 2002-09-18 DK DK02765268T patent/DK1446119T3/da active
- 2002-09-18 ES ES02765268T patent/ES2259098T3/es not_active Expired - Lifetime
- 2002-09-18 MX MXPA04002500A patent/MXPA04002500A/es active IP Right Grant
- 2002-09-18 EA EA200400444A patent/EA008165B1/ru unknown
- 2002-09-18 CN CNB028182871A patent/CN1290502C/zh not_active Expired - Lifetime
- 2002-09-18 EP EP06075452A patent/EP1661570A3/en not_active Withdrawn
- 2002-09-18 NZ NZ531792A patent/NZ531792A/en not_active IP Right Cessation
- 2002-09-18 KR KR1020047003882A patent/KR100810872B1/ko not_active Expired - Lifetime
- 2002-09-18 SI SI200230311T patent/SI1446119T1/sl unknown
- 2002-09-18 HU HU0402075A patent/HU226527B1/hu unknown
- 2002-09-18 US US10/489,655 patent/US7652030B2/en not_active Expired - Lifetime
- 2002-09-18 WO PCT/IB2002/003828 patent/WO2003024433A2/en not_active Ceased
- 2002-09-18 PL PL370536A patent/PL208686B1/pl unknown
- 2002-09-18 AT AT02765268T patent/ATE318601T1/de active
- 2002-09-18 PT PT02765268T patent/PT1446119E/pt unknown
-
2004
- 2004-03-12 NO NO20041070A patent/NO334441B1/no not_active IP Right Cessation
-
2009
- 2009-12-11 US US12/654,145 patent/US8450339B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL370536A1 (pl) | Kompozycje do leczenia przeziębienia | |
| MXPA04005865A (es) | Suministro de aminoglucosidos a los pulmones. | |
| WO2002070510A3 (de) | Aminodicarbonsäurederivate mit pharmazeutischen eigenschaften | |
| JO2311B1 (en) | Alkyl inhibitors Ariel phosphodiesterase-4 | |
| BR9812361A (pt) | Uso de combinações compreendendo anti-histaminas não-sedantes e drogas alfa-adrenérgicas para o tratamento tópico de rinite/conjutivite e sintomas de infecção por vìrus, semelhante a infecção por vìrus e/ou resfriado | |
| WO2003009838A1 (en) | Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus | |
| MXPA04002825A (es) | Derivados de quinolina como antagonistas de neuropeptido y. | |
| NO2007010I1 (no) | Sitagliptin, eventuelt i form av et farmasoytisk akseptabelt salt | |
| TW200504078A (en) | Therapeutically active compounds and their use | |
| MXPA03010761A (es) | Combinaciones farmaceuticas. | |
| NO307495B1 (no) | Anvendelse av riluzol ved fremstilling av medikamenter for behandling av Parkinsons sykdom og Parkinsonske syndromer | |
| GB0222514D0 (en) | Organic compounds | |
| AU2002307049A1 (en) | Use of mglur5 antagonists in the manufacture of a medicament in the treatment of autism, mental retardation, schizophrenia | |
| AU7226301A (en) | Pyridoxine and pyridoxal analogues: cardiovascular therapeutics | |
| WO2002088100A3 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
| WO2003087049A3 (de) | Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum | |
| DE60322417D1 (en) | 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1,8-naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren | |
| WO2002072584A3 (en) | Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders | |
| WO2004082706A3 (en) | Ifn-beta alone or in combination with other medicaments for treating alzheimer's disease and demens disorders | |
| SG152257A1 (en) | Topical preparation containing ambroxol | |
| BR0212329A (pt) | Métodos para tratar doença pulmonar | |
| WO2002065989A3 (en) | Aminoglycoside treatment for lysosomal storage diseases | |
| CA2436511A1 (en) | Use of flumazenil to produce a medicament for the treatment of cocaine dependency | |
| WO2005039483A3 (en) | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity | |
| BG105984A (bg) | Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RECP | Rectifications of patent specification |